Effectiveness of Telemedicine Interventions In Diabetes Management At Primary Care Settings In Asia: A Systematic Review Protocol

Amity  Das; Pawna  Kaushal; Disha  Agarwal; Megha  Sharma

doi:10.5455/njcm.20210508080411

Authors

Amity Das All India Institute of Medical Sciences, Rishikesh
Pawna Kaushal All India Institute of Medical Sciences, Rishikesh
Disha Agarwal All India Institute of Medical Sciences, Rishikesh
Megha Sharma All India Institute of Medical Sciences, Rishikesh

DOI:

https://doi.org/10.5455/njcm.20210508080411

Keywords:

Diabetes Mellitus, Telemedicine, Primary Health Care, Asia

Abstract

Background: This systematic review will focus on the effectiveness of Telemedicine interventions on diabetic management at primary care settings in Asia. The objectives of this systematic review and meta-analysis are to synthesize the clinical effectiveness and to compare the effectiveness of Telemedicine interventions in the diabetes management in Asia.

Methodology: The conducting and reporting of this review will adhere to the PRISMA guidelines. The search strategy will include MeSH terms related to Diabetes, Telemedicine, Diabetic management, Primary Healthcare, Effectiveness, and Asia to find relevant studies. Other synonymous words will be searched using Boolean operator “AND”/”OR” on PUBMED, EMBASE, SCOPUS, COCHRANE. Randomized controlled trials examining the effectiveness of telemedicine interventions in the management of Diabetes Mellitus patients at Primary Care settings in Asia will be included. A random effects meta-analysis will be conducted with the REVMAN software version 5.3.5. Cumulative and comparative meta-analysis will be done with STATA software version SE16.

Discussion: This review and meta-analysis will be among the first to give an extensive purview on the effectiveness of telemedicine in diabetes management at Primary Care settings in Asian population.

Systematic review registration: The protocol has been registered at the International Prospective Register of Systematic Reviews (PROSPERO registration number: 42021210002).

References

International Diabetes Federation - Facts & figures [Internet]. [cited 2021 Apr 13]. Available from: https://www.idf.org/ aboutdiabetes/what-is-diabetes/facts-figures.html

WHO | Telehealth [Internet]. [cited 2021 Apr 13]. Available from: https://www.who.int/gho/goe/telehealth/en/

Klonoff DC. Using Telemedicine to Improve Outcomes in Dia-betes—An Emerging Technology. J Diabetes Sci Technol Online. 2009 Jul;3(4):624–8.

Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group. Pre-ferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009 Jul 21;6(7):e1000097.

World Health Organization, editor. Telemedicine: opportuni-ties and developments in member states: report on the sec-ond Global survey on eHealth [Internet]. Geneva, Switzer-land: World Health Organization; 2010. 93 p. (Global observa-tory for eHealth series). Available from: https://www.who.int/ goe/publications/goe_telemedicine_2010.pdf

Lee SWH, Ooi L, Lai YK. Telemedicine for the Management of Glycemic Control and Clinical Outcomes of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Random-ized Controlled Studies. Front Pharmacol [Internet]. 2017 May 30 [cited 2021 Apr 13];8. Available from: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC5447671/

Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Col-laboration’s tool for assessing risk of bias in randomised tri-als. BMJ. 2011 Oct 18;343:d5928.

Mbuagbaw L, Rochwerg B, Jaeschke R, et al. Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev. 2017 Apr 12;6(1):79.